Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $21.15 Average Price Target from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given an average recommendation of “Hold” by the sixteen research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $21.1538.

A number of research analysts have issued reports on the company. KeyCorp decreased their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, December 3rd. Leerink Partners boosted their target price on shares of Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research note on Thursday, February 26th. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Finally, Mizuho dropped their price target on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Rockefeller Capital Management L.P. boosted its position in Acadia Healthcare by 7,490.9% during the fourth quarter. Rockefeller Capital Management L.P. now owns 70,368 shares of the company’s stock worth $999,000 after purchasing an additional 69,441 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after purchasing an additional 5,203 shares during the period. Alpine Global Management LLC purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $174,000. Aristides Capital LLC acquired a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $196,000. Finally, Invesco Ltd. raised its stake in shares of Acadia Healthcare by 58.7% during the 4th quarter. Invesco Ltd. now owns 727,846 shares of the company’s stock worth $10,328,000 after buying an additional 269,140 shares during the period.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $22.69 on Friday. The firm’s fifty day moving average is $18.11 and its two-hundred day moving average is $18.72. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of -1.86, a PEG ratio of 7.83 and a beta of 0.74. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. Acadia Healthcare has a one year low of $11.43 and a one year high of $31.04.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Research analysts expect that Acadia Healthcare will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.